TVMR With the INNOVALVE System Trial - Early Feasibility Study

Part of paid clinical trials in Los Angeles, California.

Sponsor
Edwards Lifesciences
Study ID
NCT04919980
Status
Recruiting

Conditions

  • Mitral Valve Regurgitation (Degenerative or Functional)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • INNOVALVE system — DEVICE
    INNOVALVE system

Study Details

Study to evaluate the safety and performance of the INNOVALVE system

Key Dates

Start date
Sep 1, 2022
Status verified
Apr 2026
Primary completion
Jul 1, 2026
Completion
Jul 1, 2031

Study Design

Enrollment
65 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment
    MV replacement with INNOVALVE system

Primary Outcome Measure

Absence of implant or delivery related serious adverse events at 30 Days [ Time Frame: 30 days ]

Central Contacts

Locations (20)

FacilityCityStateZIPSite coordinators
Cedars-SinaiLos AngelesCalifornia90048
Mitch Gheorghiu
310-407-9553
Rajendra Makkar, MD (PRINCIPAL_INVESTIGATOR)
Stanford UniversityPalo AltoCalifornia94305
Anushka Marathe
650-497-0903
Alan Yeung, MD (PRINCIPAL_INVESTIGATOR)
Naples Comprehensive HealthNaplesFlorida34102
Kathy Byrd
239-624-8113
Robert Cubeddu, MD (PRINCIPAL_INVESTIGATOR)
Emory UniversityAtlantaGeorgia30308
Elizabeth Charles
404-686-1249
Adam Greenbaum, MD (PRINCIPAL_INVESTIGATOR)
Piedmont Heart InstituteAtlantaGeorgia30309
Jennifer Bolivar Aldana
770-846-0344
Vinod Thourani, MD (PRINCIPAL_INVESTIGATOR)
NorthwesternChicagoIllinois60611
BCVI Clinical Trials Unit
312-926-4000
Charles Davidson, MD (PRINCIPAL_INVESTIGATOR)
University of Michigan Hospital and Health SystemsAnn ArborMichigan48109
Keoni Fordham
734-763-6551
Stanley Chetcuti, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota555905
Carl Griffin
Mackram Eleid, MD (PRINCIPAL_INVESTIGATOR)
Saint Luke's HospitalKansas CityMissouri64111
Brianna Vann
816-932-9614
Adnan Chhatriwalla, MD (PRINCIPAL_INVESTIGATOR)
Morristown Medical CenterMorristownNew Jersey07960
Catherine Van Zile
973-971-5951
Gennaro Giustino, MD (PRINCIPAL_INVESTIGATOR)
Northwell HealthManhassetNew York11030
Samantha Annunziato
516-600-1475
Bruce Rutkin, MD (PRINCIPAL_INVESTIGATOR)
CornellNew YorkNew York10021-
NewYork-Presbyterian / Columbia UniversityNew YorkNew York10032
Treena Williams
Susheel Kodali, MD (PRINCIPAL_INVESTIGATOR)
Cleveland ClinicClevelandOhio44195
Emily Tylicki
216-444-6950
Samir Kapadia, MD (PRINCIPAL_INVESTIGATOR)
OhioHealth Research InstituteColumbusOhio43214
Katy Monnin
614-566-5768
Carlos Sanchez, MD (PRINCIPAL_INVESTIGATOR)
Steven Yakubov, MD (SUB_INVESTIGATOR)
Oregon Health & Science UniverstiyPortlandOregon97239
Emmanuel Mills, MD
503-494-3925
Firas Zahr, MD (PRINCIPAL_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Kelli Cook
215-459-4478
Paul Fiorilli, MD (PRINCIPAL_INVESTIGATOR)
Ascension Saint ThomasNashvilleTennessee37205
Emily Normandin
615-222-3852
Andrew Morse, MD (PRINCIPAL_INVESTIGATOR)
Vanderbilt University Medical CenterNashvilleTennessee37203
Kathy Adams
615-322-9845
Natalie Jackson
615-343-1782
Colin M Barker, MD (PRINCIPAL_INVESTIGATOR)
Swedish Medical CenterSeattleWashington98122
Zaw Nu Dan
206-215-2431
Sidakpal Panaich, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA